
Join to view full profile
17087 Ryton LaneBoca Raton, FL 33496
Phone+1 404-798-7152
Dr. Lentnek is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Infectious Disease, 1973 - 1975
University of Pennsylvania Health SystemResidency, Internal Medicine, 1973 - 1975
George Washington UniversityResidency, Internal Medicine, 1972 - 1973
University of ConnecticutResidency, Internal Medicine, 1969 - 1970
Hartford HospitalInternship, Transitional Year, 1968 - 1969
Certifications & Licensure
FL State Medical License 2026 - 2028
NY State Medical License 1971 - 2028
NJ State Medical License 1990 - 2025
GA State Medical License 1993 - 2021
CT State Medical License 1971 - 2016
PA State Medical License 1973 - 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease
National Board of Physicians and Surgeons Infectious Disease
National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Teacher of the Year AOA, 2009
Clinical Trials
Publications & Presentations
PubMed
- 57 citationsA randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE studyMartin E. Stryjewski, Arnold Lentnek, William O'Riordan, John Pullman, Paul A. Tambyah
BMC Infectious Diseases. 2014-05-23 - 15 citationsTelavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.Martin E. Stryjewski, Steven L. Barriere, Ethan Rubinstein, Fredric C. Genter, Arnold Lentnek
International Journal of Antimicrobial Agents. 2013-10-01 - 7 citationsPrevalence of beta-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physici...Alexander J. Kallen, Susan E. Beekmann, Brandi Limbago, Arnold L. Lentnek, Philip M. Polgreen
Diagnostic Microbiology and Infectious Disease. 2011-11-01
Industry Relationships
- Consultant, Gerson Lehrman Group2010 - Present
- Consultant, Guidepoint Global2010 - Present
- Consultant, Senzar Capital Management2008 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: